Research Feeds

View All
1H NMR- based metabolomics approaches as non-invasive tools for diagnosis of endometriosis A Comparative Study of Blood Levels of Manganese, Some Macroelements and Heavy Metals in Obese and Non-Obese Polycystic Ovary Syndrome Patients A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist? A comprehensive analysis of breast cancer microbiota and host gene expression A comprehensive analysis of breast cancer microbiota and host gene expression A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women A metabonomics approach as a means for identification of potentialbiomarkers for early diagnosis of endometriosis A More Diverse Cervical Microbiome Associates with Better Clinical Outcomes in Patients with Endometriosis: A Pilot Study A Multi-Omic Systems-Based Approach Reveals Metabolic Markers of Bacterial Vaginosis and Insight into the Disease A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota A Review of the Anti-inflammatory Properties of Clindamycin in the Treatment of Acne Vulgaris A Systematic Review and Meta-Analysis of Premenstrual Syndrome with Special Emphasis on Herbal Medicine and Nutritional Supplements. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS)

Metabolomic Signature of Endometriosis

December 23, 2024

The chronic inflammatory state of endometriosis affects energy metabolism, particularly altering glutamine and glutamate levels in tissues. These shifts in amino acid, lipid, sugar, and organic acid metabolisms create a distinct profile for endometriosis.

Last Updated: December 23, 2024

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Overview

The metabolomic signature of endometriosis features increased protein turnover, leading to higher blood amino acid levels from catabolic damage. In contrast, alanine, lysine, phenylalanine, and leucine levels drop in endometrial tissues but rise in serum, offering promising diagnostic markers. The chronic inflammatory state of endometriosis affects energy metabolism, particularly altering glutamine and glutamate levels in tissues. These shifts in amino acid, lipid, sugar, and organic acid metabolisms create a distinct profile for endometriosis. [1][2] These metabolomic signatures open avenues for non-invasive diagnostics and new therapeutic strategies. [3]

What is the metabolomic signature of endometriosis?

Biomarkers

Serum Concentrations

Amino Acids

⬆ Alanine⬆ Lysine⬆ Phenylalanine⬆ Leucine⬆ Valine⬆ Threonine⬆ Taurine⬇ Arginine⬇ Leucine

Lipids

⬆ Sphyngomielins⬆ Ether-phospholipids

Sugars

⬇ Glucose

Organic Acids

⬆ Lactate  ⬆ 2-Hydroxybutyrate ⬆ 3-Hydroxybutyrate

Other metabolites

⬆ 2-Methoxyestradiol⬆ 2-Methoxyestrone⬆ Dehydroepiandrosterone⬆ Androstenedione⬆ Cholesterol⬇ Primitive bile acids [x]⬆ Acyl-carnitine (long-chain)

Sample Tissue
Biomarkers

Endometrial tissue 

⬇ Alanine⬇ Lysine⬇ Phenylalanine⬇ Leucine

Endometriotic Tissue

⬇ Formate

Endometrial fluid

⬇ Monohexosylceramides⬇⬆Ceramides⬆Glycerophospholipids ⬆Glycerolipids

Follicular fluid

⬆Phosphatidylcholines

Adipose and Peripheral tissue

⬆ Estradiol

Cerebral tissue

⬆ Glutamine

Urine

⬆ Taurine⬆ Valine⬆ Guanidino-succinate⬆ Creatinine⬆ 2-Hydroxyisovalerate
[4][5] [6][7][8][9][10]

Metabolomic Signature

Metabolomic signatures are unique metabolite patterns linked to specific biological conditions, identified through metabolomics. They reveal underlying biochemical activities, aiding in disease diagnosis, biomarker development, and personalized medicine. The microbiome significantly affects these signatures, influencing health and disease outcomes through metabolic interactions.

Endometriosis

Endometriosis involves ectopic endometrial tissue causing pain and infertility. Validated and Promising Interventions include Hyperbaric Oxygen Therapy (HBOT), Low Nickel Diet, and Metronidazole therapy.

References

  1. Metabolomics reveals perturbations in endometrium and serum of minimal and mild endometriosis.. Dutta M, Singh B, Joshi M, et al.. (Sci Rep. April 24, 2018)
  2. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis.. Dutta M, Joshi M, Srivastava S, Lodh I, Chakravarty B, Chaudhury K.. (Mol Biosyst. (2012))
  3. 1H NMR- based metabolomics approaches as noninvasive tools for diagnosis of endometriosis. Ghazi N, Arjmand M, Akbari Z, Mellati AO, Saheb-Kashaf H, Zamani Z.. (Int J Reprod Biomed. January 14, 2016.)
  4. Metabolomics reveals perturbations in endometrium and serum of minimal and mild endometriosis.. Dutta M, Singh B, Joshi M, et al.. (Sci Rep. April 24, 2018)
  5. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis.. Dutta M, Joshi M, Srivastava S, Lodh I, Chakravarty B, Chaudhury K.. (Mol Biosyst. (2012))
  6. Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. K. Vouk, N. Hevir, M. Ribič-Pucelj, G. Haarpaintner, H. Scherb, J. Osredkar, G. Möller, C. Prehn, T. Lanišnik Rižner, J. Adamski.. (Human Reproduction, October 2012.)
  7. Lipidomic profiling of endometrial fluid in women with ovarian endometriosis.. Francisco Domínguez, Marcos Ferrando, Patricia Díaz-Gimeno, Fernando Quintana, Gemma Fernández, Inés Castells, Carlos Simón.. (Biology of Reproduction, April 2017)
  8. Potential role of aromatase inhibitors in the treatment of endometriosis.. Abu Hashim H.. (Int J Womens Health. July 21, 2014.)
  9. Functional Connectivity is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain.. As-Sanie S, Kim J, Schmidt-Wilcke T, et al.. (J Pain. 2016)
  10. Nuclear magnetic resonance metabolomic profiling of urine provides a noninvasive alternative to the identification of biomarkers associated with endometriosis.. Vicente-Muñoz S, Morcillo I, Puchades-Carrasco L, Payá V, Pellicer A, Pineda-Lucena A.. (Fertil Steril. 2015)

Dutta M, Joshi M, Srivastava S, Lodh I, Chakravarty B, Chaudhury K.

A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis.

Mol Biosyst. (2012)

Read Review

Ghazi N, Arjmand M, Akbari Z, Mellati AO, Saheb-Kashaf H, Zamani Z.

1H NMR- based metabolomics approaches as noninvasive tools for diagnosis of endometriosis

Int J Reprod Biomed. January 14, 2016.

Read Review

Dutta M, Joshi M, Srivastava S, Lodh I, Chakravarty B, Chaudhury K.

A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis.

Mol Biosyst. (2012)

Read Review

K. Vouk, N. Hevir, M. Ribič-Pucelj, G. Haarpaintner, H. Scherb, J. Osredkar, G. Möller, C. Prehn, T. Lanišnik Rižner, J. Adamski.

Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis

Human Reproduction, October 2012.

Francisco Domínguez, Marcos Ferrando, Patricia Díaz-Gimeno, Fernando Quintana, Gemma Fernández, Inés Castells, Carlos Simón.

Lipidomic profiling of endometrial fluid in women with ovarian endometriosis.

Biology of Reproduction, April 2017

Abu Hashim H.

Potential role of aromatase inhibitors in the treatment of endometriosis.

Int J Womens Health. July 21, 2014.

Vicente-Muñoz S, Morcillo I, Puchades-Carrasco L, Payá V, Pellicer A, Pineda-Lucena A.

Nuclear magnetic resonance metabolomic profiling of urine provides a noninvasive alternative to the identification of biomarkers associated with endometriosis.

Fertil Steril. 2015

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.